Membrane Separations

Protein Purification: Principles, High Resolution Methods, and Applications: Third Edition

Volumn , Issue , 2011, Pages 279-317

  Walter, Joachim K ^a   Jin, Zuwei ^b   Jornitz, Maik W ^c   Gottschalk, Uwe ^c  

^a Lot 1 Persiaran Negeri BBN   (Malaysia)

^b GE Healthcare Life Sciences   (China)

^c SARTORIUS STEDIM BIOTECH GMBH   (Germany)

Author keywords

Other separation methods and related techniques membrane separations, protein purification procedures, and membrane based separation steps; Static filtration (dead end filtration, DEF or normal flow filtration, NFF) simple arrangement of a membrane and fluid path for achieving filtration; Tangential flow filtration (TFF), or cross flow filtration, (CFF) configuration of filtration technology, process fluid directed tangentially across membrane surface

Indexed keywords

HEAT TREATING FURNACES; MEMBRANES;

CROSS FLOW FILTRATION; DEAD-END FILTRATION; MEMBRANE SEPARATION;

MICROFILTRATION;

EID: 80051885317     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470939932.ch12     Document Type: Chapter

References (60)

1. PDA Technical Report # 26, Sterilizing Filtration of Liquids, PDA J. Pharm. Sci. Technol., Vol. 62, Number S5 (2008).
2. M.W. Jornitz, T.H. Meltzer, H. Bromm, P.M. Priebe, Gen. Eng. News 24, 50-51 (2004).
3. M.W. Jornitz, T.H. Meltzer, H. Bromm, P.M. Priebe, PDA J. Pharm. Sci. Tech. 59, 96-101 (2005).
4. T.H. Meltzer, M.W. Jornitz, Pharmaceutical Filtration-The Management of Organism Removal, PDA, Bethesda, MD, DHI Publishing LLC, River Grove, IL (2006).
5. Committee D19. F 838-05 Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration, American Society for Testing and Materials (ASTM) (2005).
6. M.W. Jornitz, T.H. Meltzer, Filtration Handbook-Integrity Testing, PDA, Bethesda, MD, DHI Publishing LLC, River Grove, IL (2003).
7. M.W. Mittleman, M.W. Jornitz, T.H. Meltzer, Bacterial cell size and surface charge characteristics relevant to filter validation studies, PDA J. Pharm. Sci. Tech. 52, 37-42 (1998).
8. A.L. Zydney, Membrane Fouling, In: L.J. Zeman & A.L. Zydney (eds) Microfiltration and Ultrafiltration: Principles and Applications, Marcel Dekker, New York, NY, pp. 397-446 (1966).
9. S. Dumitriu, C. Dumitriu-Medvichi, Hydrogel and General Properties of Biomaterials, In: S. Dumitriu (ed.) Polymeric Biomaterials, Marcel Dekker, New York, NY (1994).
10. P. Soelkner, J. Rupp, Cartridge Filters, In: T.H. Meltzer & M.W. Jornitz (eds) Filtration in the Biopharmaceutical Industry, Marcel Dekker, New York, NY, pp. 145-168 (1998).
11. EMEA-CPMP QWP/486/95 Note for Guidance on Manufacture of the Finished Dosage Form (April 1996).
12. M. Dosmar, S. Pinto, Cross-flow ultrafiltration. In: T.H. Meltzer & M.W. Jornitz (eds) Filtration and Purification in the Biopharmaceutical Industry, Informa Healthcare, New York, pp. 495-542 (2006).
13. L.J. Zeman, A.L. Zydney, Microfiltration and Ultrafiltration. Principles and Applications. Marcel Dekker, New York (1996).
14. H.J. Spanier, Pharm. Technol. Eur. 15, 45-51 (2003).
15. M.W. Jornitz, P.G. Soelkner, T.H. Meltzer, PDA J. Pharm. Sci. Tech. 56, 192-196 (2002).
16. M. Dosmar, F. Meyeroltmanns, M. Gohs, BioProcess Int. 3, 40-50 (2005).
17. M. Dosmar, BioProcess Int. 3, 62-66 (2005).
18. W.F. Blatt, A. Dravid, A.S. Michaels, L. Nelsen, Solute polarization and cake formation in membrane ultrafilters: causes, consequences, and control techniques. In: M. Bier (ed.) Membrane Processes in Industry and Biomedicine, Plenum Press, New York, pp. 65-68 (1971).
19. M. Dosmar, D. Brose, Crossflow ultrafiltration. In: T.H. Meltzer & M.W. Jornitz (eds) Filtration in the Biopharmaceutical Industry, Marcel Dekker, New York, pp. 493-532 (1998).
20. M.W. Jornitz, T.H. Meltzer, Filtration Handbook: Liquids, PDA Publications, Bethesda, MD (2004).
21. M. Kalyanpur, Downstream processing in the biotechnology industry: an overview. In: M.A. Desai (ed.) Downstream Processing of Proteins: Methods and Protocols. Methods in Biotechnology 9, Humana Press, Totowa, NJ, pp. 1-10 (2000).
22. K.J. Morrow Jr, Frontiers in bioprocessing. In: E.S. Langer (ed.) Advances in Large Scale Biomanufacturing and Scale-Up Production, 2nd edn, ASM Press/BioPlan Associates, Inc., Rockville, MD, pp. 1-35 (2007).
23. A. Shukla, J.R. Kandula, Harvest and recovery of monoclonal antibodies: cell removal and clarification. In: U. Gottschalk (ed.) Process Scale Purification of Antibodies, John Wiley & Sons (2009).
24. K.P. Anderson, Y.S. Lie, M.A. Low, S.R. Williams, E.H. Fennie, T.P. Ngyen, F.M. Wurm, J. Virol. 64, 2021-2032 (1990).
25. J.K. Walter, F. Nothelfer, W. Werz, Validation of viral safety for pharmaceutical proteins. In: G. Subramanian (ed.) Bioseparation and Bioprocessing, Vol. 1, Wiley-VCH, Weinheim, pp. 465-496 (1998).
26. J. Zhou, H. Dehghani, Development of viral clearance strategies for large-scale monoclonal antibody production. In: E.S. Langer (ed.) Advances in Large Scale Biomanufacturing and Scale-Up Production, 2nd edn, ASM Press/BioPlan Associates, Inc., Rockville, MD, pp. 1-28 (2007).
27. International Conference on Harmonization. Q5A, Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, Geneva, Switzerland (1998.)
28. EMEA. Guideline on Virus Safety Evaluation of Biotechnological Investigational Medicinal Products, EMEA/CHMP/BWP/398498/2005-corr. EMEA: London (2006).
29. CPMP/BWP/268/95. Note for Guidance on Virus Validation Studies (1996).
30. J. Zhou, H. Dehghani, Am. Pharm. Review 9, 74-82 (2006).
31. K. Brorson, S. Krejci, K. Lee, E. Hamilton, K. Stein, Y. Xu, Biotechnol. Bioeng. 82, 321-329 (2003).
32. B. Horowitz, E. Ben-Hur, Ann. Med. 32, 475-484 (2000).
33. J. Wang, A. Mauser, S.F. Chao, K. Remington, R. Treckmann, K. Kaiser, D. Pifat, J. Hotta, Vox Sanguinis 86, 230-238 (2004).
34. T. Ireland, H. Lutz, M. Siwak, G. Bolton, BioPharm Int. 14, 38-44 (2004).
35. S. Ray, K. Tarrach, Biopharm. Int. Spet. 2008, 50-58 (2008).
36. M.W. Phillips, G. Bolton, M. Krishnan, J.J. Lewnard, B. Raghunath, Viral filtration process design and implementation. In: A.A. Shukla, M.R. Etzel, S. Gadam (eds) Process Scale Bioseparations for the Biopharmaceutical Industry, CRC Press, Boca Raton, FL, pp. 333-365 (2007).
37. M. Farshid, R.E. Taffs, D. Scott, D.M. Asher, K. Brorson, Curr. Opin. Biotechnol. 16, 561-567 (2005).
38. A. Immelmann, K. Kellings, O. Stamm, K. Tarrach, BioProcess Int. 3, 38-45 (2005).
39. S. Lute, M. Bailey, J. Combs, M. Sukumar, K. Brorson, Biotechnol. Appl. Biochem. 47, 141-151 (2007).
40. K. Tarrach, A. Meyer, J.E. Dathe, H. Sun, BioPharm Int. 20, 58-63 (2007).
41. J. Zhou, F. Solano, T. Hong, M. Shearer, T. Tressel, Biotechnol. Bioeng. 100, 488-496 (2008).
42. S. Nakao, H. Osada, H. Kurata, T. Tsuru, S. Kimura, Desalination 70, 191-205 (1988).
43. D.B. Burns, A.L. Zydney, Biotechnol. Bioeng. 64, 27-37 (1999).
44. K. Gebauer, J. Thömmes, M.-R. Kula, Biotechnol. Bioeng. 54, 181-189 (1997).
45. H. Knudsen, R. Fahrner, Y. Xu, L. Norling, G. Blank, J. Chromatogr. A 907, 145-154 (2001).
46. R. Gosh, J. Chromatogr. A 952, 13-27 (2002).
47. J. Zhou, T. Tressel, Biotechnol. Prog. 22, 341-349 (2006).
48. A. Arunakumari, J. Wang, Purification of human monoclonal antibodies: non-protein A strategies. In: U. Gottschalk (ed.) Process Scale Purification of Antibodies, John Wiley & Sons, Inc., Hoboken, NJ, pp. 103-123 (2009).
49. J. Zhou, T. Tressel, U. Gottschalk, F. Solamo, A. Pastor, S. Dermawan, T. Hong, O. Reif, J. Mora, F. Hutchison, M. Murphy, J. Chromatogr. A 1134, 66-73 (2006).
50. U. Gottschalk, Biotechnol. Prog. 24, 496-503 (2008).
51. J.K. Walter, Strategies and considerations for advanced economy in downstream processing of biopharmaceutical proteins. In: G. Subramanian (ed.) Bioseparation and Bioprocessing. Processing, Quality and Characterization, Economics, Safety, and Hygiene, Wiley-VCH, New York, pp. 447-460 (1998).
52. U. Gottschalk, Adv. Biochem. Eng. Biotechnol. 115, 171-183 (2010).
53. B. Kelley, Biotechnol. Prog. 23, 995-1008 (2007).
54. B. Kelley, G. Blank, A. Lee, Downstream processing of monoclonal antibodies: current practices and future opportunities. In: U. Gottschalk (ed.) Process Scale Purification of Antibodies, John Wiley & Sons, Inc., pp. 1-24 (2009).
55. R.R. Deshmukh, T.N. Warner, F. Hutchison, M. Murphy, W.E. Leitch 2nd, P. De Leon, G.S. Srivatsa, D.L. Cole, Y.S. Sanghvi, J. Chromatogr. A 890, 179-192 (2000).
56. A.G. Grunwald, M.S. Shields, Anal. Biochem. 296, 138-141 (2001).
57. S. Zhang, A. Krivosheyeva, S. Nochumson, Biotechnol. Appl. Biochem. 37, 245-249 (2003).
58. M.A. Teeters, S.E. Conrardy, B.L. Thomas, T.W. Root, E.N. Lightfoot, J. Chromatogr. A 989, 165-173 (2003).
59. M. Kuiper, R.M. Sanches, J.A. Walford, N.K. Slater, Biotechnol. Bioeng. 80, 445-453 (2002).
60. R. Specht, B. Han, S.R. Wickramasinghe, J.O. Carlson, P. Czermak, A. Wolf, O.W. Reif, Biotechnol. Bioeng. 88, 465-473 (2004).